Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

α-Synuclein in Parkinson's disease and advances in detection
Rong Chen, Xuan Gu, Xiaoying Wang
Clinica Chimica Acta (2022) Vol. 529, pp. 76-86
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Herbal medicine and gut microbiota: exploring untapped therapeutic potential in neurodegenerative disease management
Yueyue Guan, Guo-hua Tang, Lei Li, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 2, pp. 146-164
Open Access | Times Cited: 14
Transcriptomics of Human Brain Tissue in Parkinson’s Disease: a Comparison of Bulk and Single-cell RNA Sequencing
Michael R. Fiorini, Allison A. Dilliott, Rhalena A. Thomas, et al.
Molecular Neurobiology (2024)
Open Access | Times Cited: 9
Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system
Qian Luo, Jiaying Yang, Mei Yang, et al.
Materials Today Bio (2025) Vol. 31, pp. 101457-101457
Open Access | Times Cited: 1
Therapeutic application of mesenchymal stem cells derived exosomes in neurodegenerative diseases: A focus on non-coding RNAs cargo, drug delivery potential, perspective
Mohaddeseh Hedayat, Mahdi Ahmadi, Maryam Shoaran, et al.
Life Sciences (2023) Vol. 320, pp. 121566-121566
Closed Access | Times Cited: 19
Microglial Activation and Oxidative Stress in PM2.5-Induced Neurodegenerative Disorders
Jie Song, Keyang Han, Ya Wang, et al.
Antioxidants (2022) Vol. 11, Iss. 8, pp. 1482-1482
Open Access | Times Cited: 27
Applications of Raman spectroscopy in the diagnosis and monitoring of neurodegenerative diseases
Chao Chen, Jinfeng Qi, Ying Li, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 5
Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes
Giuseppe Lisco, Anna De Tullio, Michele Iovino, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2993-2993
Open Access | Times Cited: 11
Ginsenosides Rg1, Rb1 and rare ginsenosides: promising candidate agents for Parkinson's disease and Alzheimer's disease and network pharmacology analysis
Mingchun Jiang, Jiaxin Chi, Yifan Qiao, et al.
Pharmacological Research (2025) Vol. 212, pp. 107578-107578
Open Access
Association between deep gray matter iron deposition and clinical symptoms in Parkinson’s disease: a quantitative susceptibility mapping study
Hui Zhao, Qiuhong Ji, Zhongzheng Jia, et al.
Frontiers in Neurology (2025) Vol. 15
Open Access
Surface-enhanced Raman scattering for the detection of biomarkers of neurodegenerative diseases: A review
Chentao Li, Yinglin Wang, Yafang Wu, et al.
TrAC Trends in Analytical Chemistry (2025) Vol. 185, pp. 118173-118173
Closed Access
Protective effects of harpagoside on mitochondrial functions in rotenone‑induced cell models of Parkinson's disease
Juan Lang, Zhongkui Xiong
Biomedical Reports (2025) Vol. 22, Iss. 4
Open Access
Epigenetic regulation of iron metabolism and ferroptosis in Parkinson’s disease: Identifying novel epigenetic targets
Xiaodie Gao, Jun Ding, Junxia Xie, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Activating autophagy to eliminate toxic protein aggregates with small molecules in neurodegenerative diseases
Yuqi Fu, Jin Zhang, Rui Qin, et al.
Pharmacological Reviews (2025), pp. 100053-100053
Closed Access
Apigenin enhances Nrf2-induced chaperone-mediated autophagy and mitigates α-synuclein pathology: Implications for Parkinson's disease therapy
Yibin Huang, Lulu Tian, Ziwen Zhu, et al.
Phytomedicine (2025), pp. 156652-156652
Closed Access
A Mendelian randomization study on association of alpha-synuclein and GPNMB with Parkinson’s disease risk and progression
Lizhi Li, Jiabin Liu, Yige Wang, et al.
Molecular Neurobiology (2025)
Open Access
Sortilin Expression Levels and Peripheral Immunity: A Potential Biomarker for Segregation between Parkinson’s Disease Patients and Healthy Controls
Maria Georgoula, Panagiotis Ntavaroukas, Anastasia Androutsopoulou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1791-1791
Open Access | Times Cited: 3
Implications of Butyrate Signaling Pathways on the Motor Symptomatology of Parkinson’s Disease and Neuroprotective Effects—Therapeutic Approaches: A Systematic Review
Jorge Missiego-Beltrán, Eva María Olalla-Álvarez, Ana González-Brugera, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8998-8998
Open Access | Times Cited: 3
Genetic and pharmacologic p32-inhibition rescue CHCHD2-linked Parkinson’s disease phenotypes in vivo and in cell models
Murni Tio, Rujing Wen, Cai Ning Choo, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 2
A review on nanotechnological perspective of “the amyloid cascade hypothesis” for neurodegenerative diseases
Syed M. S. Abidi, Chandni Sharma, Shiwani Randhawa, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 126821-126821
Closed Access | Times Cited: 6
Neuroprotective effects of isatin and afobazole in rats with rotenone-induced Parkinsonism are accompanied by increased brain levels of Triton X-100 soluble alpha-synuclein
О.А. Бунеева, И. Г. Капица, Victor G. Zgoda, et al.
Biomeditsinskaya Khimiya (2023) Vol. 69, Iss. 5, pp. 290-299
Open Access | Times Cited: 6
Rapid FRET Assay for the Early Detection of Alpha-Synuclein Aggregation in Parkinson’s Disease
Hang Yu, Rui Feng, Fenglin Chen, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 7, pp. 1378-1387
Closed Access | Times Cited: 1
Primary cilia in Parkinson’s disease: summative roles in signaling pathways, genes, defective mitochondrial function, and substantia nigra dopaminergic neurons
Zijiao Tian, Yixin Zhang, Jing Xu, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 1
Lipid metabolism and ageing in Caenorhabditis elegans: a complex interplay
Teresa Rubio‐Tomás, Nektarios Tavernarakis
Biogerontology (2022) Vol. 23, Iss. 5, pp. 541-557
Closed Access | Times Cited: 5
MECANISMOS MOLECULARES DA DEGENERAÇÃO NEURONAL NA DOENÇA DE PARKINSON: UMA REVISÃO BIBLIOGRÁFICA
Ana Maria Santos Cardoso, Renata Azevedo Dutra Queiroz, Luana Elisa Lugli, et al.
RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218 (2024) Vol. 5, Iss. 1, pp. e514810-e514810
Open Access
Rational design of structure‐based vaccines targeting misfolded alpha‐synuclein conformers of Parkinson's disease and related disorders
José Miguel Flores-Fernández, Verena Pesch, Aishwarya Sriraman, et al.
Bioengineering & Translational Medicine (2024) Vol. 9, Iss. 4
Open Access
Page 1 - Next Page

Scroll to top